| Item 1.01. | Entry into a Material Definitive Agreement. |
Quotient Limited (the “Company” or “we”, “us” and “our”) received consents from all of the holders (the “Consenting Holders”) of its 12% Senior Secured Notes due 2025 (the “Notes”) issued pursuant to the Indenture, dated as of October 14, 2016 (as subsequently amended, the “Indenture”), by and among the Company, the guarantors party thereto and U.S. Bank National Association, a national banking association, as trustee and collateral agent, to further amend the Indenture pursuant to the Eight Supplemental Indenture, dated as of November 21, 2022 (the “Eight Supplemental Indenture”). The Eight Supplemental Indenture has been executed by the Company, the Trustee and the other parties thereto and is in effect.
The Eighth Supplemental Indenture eliminates the Company’s obligation under the SSN Indenture to make the interest payment otherwise due on October 15, 2022 in cash, and permit the Company instead to make such interest payment “in kind” by issuing new debt securities to the noteholders. The Eighth Supplemental Indenture allows the Company to issue and deliver further SSNs (the “Further SSNs”) in an aggregate principal amount of $3,987,500 to satisfy interest due on the SSNs by way of payment in-kind. The Further SSNs have the same terms as the SSNs, except that the issuance price, the issuance date and the Initial Payment Date vary. The Further SSNs and the SSNs are treated as a single class for all purposes under the SSN Indenture, including directions provided to the Trustee, waivers, amendments, redemptions and offers to purchase, and ranks on a parity basis in right of payment and security. The Eighth Supplemental Indenture increases the permitted SSNs issuance amount under the Notes to $145,000,000 plus the October 2022 Interest Amount (being $3,987,500), and changes the redemption provisions under the Notes to allow SSNs in denominations larger than $1,000 to be redeemed in part but only in whole multiples of $1.00 in excess of $1,000.
The Company sought the amendments described above to allow the Company to preserve liquidity and avoid an event of default that would otherwise result from the Company’s failure to make a cash interest payment on or before October 17, 2022.
The above description of the Eighth Supplemental Indenture is qualified in its entirety by reference to the Eighth Supplemental Indenture, a copy of which is filed as Exhibit 4.1 hereto and is incorporated herein by reference.
On November 17, 2022, the Company received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) stating that because the Company’s ordinary shares had a closing bid price at or above $1.00 per share for a minimum of 10 consecutive business days, the Company’s ordinary shares had regained compliance with the minimum bid price requirement of $1.00 per share for continued listing on The Nasdaq Global Market, as set forth in Nasdaq Listing Rule 5450(a)(1). The Company remains subject to a listing deficiency notice for failure to meet Nasdaq’s market value of listed securities standard, as previously announced on August 9, 2022.
